Brief: Tricida Says Entered Into Manufacturing, Commercial Supply Agreement With Patheon Austria
Oct 10 (Reuters) - Tricida Inc TCDA.O :
* TRICIDA - ON OCTOBER 4, 2019, CO ENTERED INTO A
MANUFACTURING
AND COMMERCIAL SUPPLY AGREEMENT WITH PATHEON AUSTRIA GMBH & CO
KG
* TRICIDA INC - PATHEON HAS AGREED TO MANUFACTURE AND SUPPLY
VEVERIMER TO SUPPORT COMPANY'S COMMERCIALIZATION EFFORTS
* TRICIDA INC - UNDER AGREEMENT PATHEON AGREED TO
MANUFACTURE &
SUPPLY VEVERIMER TO SUPPORT CO'S DRUG DEVELOPMENT AND CLINICAL
TRIAL ACTIVITIES
* TRICIDA INC - AGREEMENT HAS AN INITIAL TERM ENDING ON JUNE
30,
2030
Source text: (http://bit.ly/2IGluiD)
Further company coverage: TCDA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Tricida
See all newsBrief: Tricida Inc - On March 9, Company And Renibus Consummated Sale Of Certain Assets
Brief: Tricida Inc Receives Notice Of Delisting From Nasdaq
Brief: Tricida Inc Filed Voluntary Petition For Relief Under Chapter 11
Brief: Tricida - On December 19, 2022, Tricida Received An Additional Letter From Patheon Referencing The Purported Termination Notice From December 7, 2022
Brief: Tricida Inc - On December 6, Received Notice From Nasdaq That Co Is Not Been In Compliance With Minimum Bid Price Requirement - Filing